References
- Banks RE, Dunn MJ, Forbes MA, Stanley A, Pappin D, Naven T, Gough M, Harnden P, Selby PJ. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings // Electrophoresis, 1999; 20:689-700
- Becker W, Rapp W, Schwick HG, Störiko KZ. Methods for the quantitative determination of plasma proteins by immunoprecipitation // Klin Chem Klin Biochem, 1968; 6:113-22
- Feng S, Lang J, Kumar A, Carey N, Hsieh B, Suchard MA., Reddy ST, Farias-Eisner R. Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection // Biomarker Insights, 2007; 2:369-375
- Fung ET, Thulasiraman V, Weinberger SR, Dalmasso EA. Protein biochips for differential profiling // (a) Curr Opin Biotechnol, 2001;12:65-69
- Fung ET, Wright GL Jr, Dalmasso EA. Proteomic strategies for biomarker identification: progress and challenges // (b) Curr Opin Mol Ther, 2000; 2:643-650
- Goufman EI, Moshkovskii SA, Tikhonova OV, Lokhov PG, Zgoda VG, Serebryakova MV, Toropygin IY, Vlasova MA, Safarova MR, Makarov OV, Archakov AI. Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions // Biochemistry (Mosc), 2006; 71(4):354-60
- Heidelberg M, Kendall FE // J Exp Med, 1935; 62:697
- Hood BL, Malehorn DE, Conrads TP, Bigbee WL. Serum proteomics using mass spectrometry // Methods Mol Biol, 2009; 520:107-28
- Jacobs I, Bast RC Jr. The CA 125 tumour-associated antigen: a review of the literature // Hum Reprod, 1989; 4:1-12
- Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, Farias-Eisner R. Characterization of serum biomarkers for detection of early stage ovarian cancer // Proteomics, 2005; 5(17):4589-96
- Lizana J, Hellsing K. Manual immunoephelometric assay of proteins, with use of polymer enhancement // Clin Chem, 1974; 20:1181-6
- MacDonald ND, Jacobs IJ. Is there a place for screening in ovarian cancer // Eur J Obstet Gynecol Reprod Biol, 1999; 82:155-157
- Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization time-of-flight mass spectrometry // Electrophoresis, 2000; 21:1164-1177
- Moore LE, Fung ET, McGuire M, Rabkin CC, Molinaro A, Wang Z, Zhang F, Wang J, Yip C, Meng XY, Pfeiffer RM. Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population // Cancer Epidemiol Biomarkers Prev, 2006; 15(9):1641-6
- Naito HK. Reliability of lipid, lipoprotein, and apolipoprotein measurements // Clin Chem, 1988; 34:84-94
- Nosov V, Su F, Amneus M, Birrer M, Robins T, Kotlerman J, Reddy S, Farias-Eisner R. Validation of serum biomarkers for detection of early-stage ovarian cancer // Am J Obstet Gynecol, 2009; 200:639
- Palmer-Toy D, Kuzdzal S, Chan, DW. Proteomic approaches to tumor marker discovery // In: Diamandis EP, Fritsche H, Lilja H, Chan DW, Schwartz M, eds. Tumor Markers Physiology, Pathobiology, Technology and Clinical Applications. Philadelphia: AACC Press; 2002; 391-400
- Paweletz CP, Gillespie JW, Ornstein DK, Simone NL, Brown MR, Cole KA, Wang QH, Huang J, Hu N, Yip TT, Rich WE, Kohn EC, Linehan WM, Weber T, Taylor P, Emmert-Buck MR, Liotta LA, Petricoin EF. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip // Drug Dev Res, 2000; 49:34-42
- Rai AJ, Zhang Z, Rosenzweig J, Shih I, Pham T, Fung ET, Sokoll LJ, Chan DW. Proteomic Approaches to Tumor Marker Discovery Identification of Biomarkers for Ovarian Cancer // Arch Pathol Lab Med, 2002; 126(12):1518-1526
- Rifai N, King ME. Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum // Clin Chem, 1986; 32:957-61
- Shih IM, Sokoll LJ, Chan DW, Tumor markers in ovarian cancer // In: Diamandis EP, Fritsche H, Lilja H, Chan DW, Schwartz M. Tumor Markers Physiology, Pathobiology, Technology and Clinical Applications. Philadelphia: AACC Press; 2002; 239-252 Siedel, J., Schiefer, S., Rosseneu, M., Bergeaud, R., De Keersgieter, W., Pautz, B., Vinaimont, N., Ziegenhorn, J. Immunoturbidimetric method for routine determinations of apolipoproteins A-I, A-I. I., and B in normo- and hyperlipemic sera compared with immunonephelometry // Clin Chem, 1988; 34:1821-5
- Tietz NW. Transferrin // In: Tietz NW. Fundamentals of clinical Chemistry. 2nd ed. Philadelphia: WB Saunders; 1976; 278-280
- Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Nasim S, Wright Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine // Am J Pathol, 2001; 158:1491-1502
- Von Eggeling F, Junker K, Fiedler W, Wollscheid V, Dürst M, Claussen U, Ernst G. Mass spectrometry meets chip technology: a new proteomic tool in cancer research // Electrophoresis, 2001; 22: 2898-2902
- Weinberger SR, Morris TS, Pawlak M. Recent trends in protein biochip technology // Pharmacogenomics, 2000; 1:395-416
- Zhang Z, Bast RC, Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, Van Haaften-Day C, Hacker NF, de Bruijn HWA, Van der Zee AGJ, Jacobs IJ, Fung ET, Chan DW. Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer // Cancer Research, 2004; 64:5882-5890
- Zhao Q, Duan W, Wu YM, Qian XH, Deng XH. Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF // Zhonghua Zhong Liu Za Zhi, 2008; 30(10):754-8